Effect of Iron and Folic Acid tablet and capsule formulation on drug compliance
Phase 4
Completed
- Registration Number
- CTRI/2018/04/013361
- Lead Sponsor
- All India Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 208
Inclusion Criteria
•Pregnant women who have not been booked earlier for the current pregnancy and are more than 12 weeks of gestation.
Exclusion Criteria
•Refusal to provide written consent
•Hematological disorder (except Anemia)
•Severe anemia requiring blood transfusion ( <7 gm%)
•Already taking IFA preparations for the current pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Adherence to tablet and capsule formulation of IFA (pill count and recall method) <br/ ><br>2.Difference between mean hemoglobin level change after 100 days of IFA (Capsule or Tablet) consumption <br/ ><br>Timepoint: At the End of the study (August 2014)
- Secondary Outcome Measures
Name Time Method 1.Association of IFA adherence with various socio-demographic and other factors <br/ ><br>2.Prevalence of various side effects of IFA preparationTimepoint: At the End of the study (August 2014)